Literature DB >> 17265104

Antigenic properties of porcine teschovirus 1 (PTV-1) Talfan strain and molecular strategy for serotyping of PTVs.

Y Kaku1, Y Murakami, A Sarai, Y Wang, S Ohashi, K Sakamoto.   

Abstract

For reliable diagnosis of porcine teschovirus (PTV) infection we created an RT-PCR-based molecular strategy for serotyping that encompassed the dominant neutralizing antigenic site of PTV, followed by phylogenetic analyses of amplicons. We identified neutralizing antigenic sites of PTV-1 Talfan strain through epitope mapping of neutralizing monoclonal antibodies (MAbs), using synthetic peptides spanning the capsid proteins. All 11 MAbs obtained recognized peptides in the EF loop ("puff") of VP2 protein. Two MAbs concurrently reacted to peptides, one in the GH loop of VP1 and one in the VP1 C terminus. Three-dimensional modeling of Talfan capsid protein predicted exposure of all these sites on the virion surface in a close line centered around puff. We then designed a single pair of degenerate primers to VP2 and amplified the region of approximately 320 bp encompassing puff in 8 PTV prototype strains and 6 field isolates. Phylogenetic analyses of the puff sequences of 11 prototype strains and 34 field isolates obtained from databanks showed that all homotypic strains (both field and prototype) were always monophyletic, except for one 'untypable' Japanese strain. This RT-PCR-based strategy appears to be a reliable surrogate for serotyping and could facilitate the diagnosis and epidemiological study of PTV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17265104     DOI: 10.1007/s00705-006-0908-7

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  9 in total

1.  Porcine teschovirus in wild boars in Hungary.

Authors:  Ákos Boros; Csaba Nemes; Péter Pankovics; Beatrix Kapusinszky; Eric Delwart; Gábor Reuter
Journal:  Arch Virol       Date:  2012-05-09       Impact factor: 2.574

2.  First report of Porcine teschovirus (PTV), Porcine sapelovirus (PSV) and Enterovirus G (EV-G) in pig herds of Brazil.

Authors:  Daiane Güllich Donin; Raquel de Arruda Leme; Alice Fernandes Alfieri; Geraldo Camilo Alberton; Amauri Alcindo Alfieri
Journal:  Trop Anim Health Prod       Date:  2013-12-22       Impact factor: 1.559

3.  The survey of porcine teschoviruses in field samples in China with a universal rapid probe real-time RT-PCR assay.

Authors:  Chaofan Zhang; Zhongtian Wang; Feng Hu; Yebing Liu; Zheng Qiu; Shun Zhou; Shangjin Cui; Ming Wang
Journal:  Trop Anim Health Prod       Date:  2012-11-09       Impact factor: 1.559

4.  Complete Coding Genome Sequence of a Putative Novel Teschovirus Serotype 12 Strain.

Authors:  C Cano-Gómez; M A Jiménez-Clavero
Journal:  Genome Announc       Date:  2016-03-10

5.  Molecular characterization of a porcine teschovirus HuN-1 isolate proliferating in PK-15 cell.

Authors:  Molin Chen; Wei Tang; Xiuguo Hua
Journal:  BMC Vet Res       Date:  2018-04-27       Impact factor: 2.741

6.  Experimental teschovirus encephalomyelitis in gnotobiotic pigs.

Authors:  M Yamada; A Miyazaki; Y Yamamoto; K Nakamura; M Ito; H Tsunemitsu; M Narita
Journal:  J Comp Pathol       Date:  2013-10-26       Impact factor: 1.311

7.  Prediction of Potential Epitopes for Peptide Vaccine Formulation Against Teschovirus A Using Immunoinformatics.

Authors:  Antara Barman; Bornali Deb; Supriyo Chakraborty
Journal:  Int J Pept Res Ther       Date:  2019-08-16       Impact factor: 1.931

8.  A Highly Conserved Epitope (RNNQIPQDF) of Porcine teschovirus Induced a Group-Specific Antiserum: A Bioinformatics-Predicted Model with Pan-PTV Potential.

Authors:  Tung-Hsuan Tsai; Chia-Yi Chang; Fun-In Wang
Journal:  Viruses       Date:  2020-10-29       Impact factor: 5.048

9.  Exploring the Cause of Diarrhoea and Poor Growth in 8-11-Week-Old Pigs from an Australian Pig Herd Using Metagenomic Sequencing.

Authors:  Tarka Raj Bhatta; Anthony Chamings; Soren Alexandersen
Journal:  Viruses       Date:  2021-08-13       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.